Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung Hung

Showing results (451-460 of 563) with videos related to

Pageof 57
Sort By:
Journal of Viral Hepatitis|April 29, 2020
Real-world effectiveness of glecaprevir/pibrentasvir and ledipasvir/sofosbuvir for mixed genotype hepatitis C infection: A multicenter pooled analysis in TaiwanWen-Nan Chiu, Chao-Hung Hung, Sheng-Nan Lu, et al.
The American Journal of Tropical Medicine and Hygiene|November 6, 2007
Aflatoxin exposure and hepatitis C virus in advanced liver disease in a hepatitis C virus endemic area in TaiwanChien-Hung Chen, Mei-Hui Wang, Jing-Houng Wang, et al.
The Journal of Antimicrobial Chemotherapy|December 17, 2011
A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practiceMing-Chao Tsai, Chuan-Mo Lee, King-Wah Chiu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 12, 2018
Clinical characteristics and prognosis of HCC occurrence after antiviral therapy for HCV patients between sustained and non-sustained respondersFai-Meng Sou, Cheng-Kun Wu, Kuo-Chin Chang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 10, 2007
P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resectionJung-Ta Kao, Seng-Kee Chuah, Chao-Cheng Huang, et al.
Journal of Hepatocellular Carcinoma|December 8, 2025
Intensity-Modulated Proton Therapy for Hepatocellular Carcinoma with Portal Vein Tumor ThrombosisChieh-Min Liu, Chia-Hsuan Lai, Yu-Ming Wang, et al.
The Journal of Antimicrobial Chemotherapy|August 18, 2012
A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapyKuo-Chin Chang, Chao-Hung Hung, Sheng-Nan Lu, et al.
Surgical Oncology|April 25, 2022
Minimally invasive surgery versus percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma: Results from a high-volume liver surgery center in East AsiaYueh-Wei Liu, Yi-Hao Yen, Wei-Feng Li, et al.
Clinical Medicine Insights. Oncology|March 7, 2024
Smoking as a Risk Factor for Very Late Recurrence in Surgically Resected Early-Stage Primary Hepatocellular CarcinomaWei-Ru Cho, Chih-Chi Wang, Mu-Jung Tsai, et al.
Journal of Gastroenterology and Hepatology|July 28, 2010
Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screeningPo-Lin Tseng, Jing-Houng Wang, Hung-Da Tung, et al.
Pageof 57

Showing results (451-460 of 563) with videos related to

Sort By:
Pageof 57
Journal of Viral Hepatitis|April 29, 2020
Real-world effectiveness of glecaprevir/pibrentasvir and ledipasvir/sofosbuvir for mixed genotype hepatitis C infection: A multicenter pooled analysis in TaiwanWen-Nan Chiu, Chao-Hung Hung, Sheng-Nan Lu, et al.
The American Journal of Tropical Medicine and Hygiene|November 6, 2007
Aflatoxin exposure and hepatitis C virus in advanced liver disease in a hepatitis C virus endemic area in TaiwanChien-Hung Chen, Mei-Hui Wang, Jing-Houng Wang, et al.
The Journal of Antimicrobial Chemotherapy|December 17, 2011
A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practiceMing-Chao Tsai, Chuan-Mo Lee, King-Wah Chiu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 12, 2018
Clinical characteristics and prognosis of HCC occurrence after antiviral therapy for HCV patients between sustained and non-sustained respondersFai-Meng Sou, Cheng-Kun Wu, Kuo-Chin Chang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 10, 2007
P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resectionJung-Ta Kao, Seng-Kee Chuah, Chao-Cheng Huang, et al.
Journal of Hepatocellular Carcinoma|December 8, 2025
Intensity-Modulated Proton Therapy for Hepatocellular Carcinoma with Portal Vein Tumor ThrombosisChieh-Min Liu, Chia-Hsuan Lai, Yu-Ming Wang, et al.
The Journal of Antimicrobial Chemotherapy|August 18, 2012
A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapyKuo-Chin Chang, Chao-Hung Hung, Sheng-Nan Lu, et al.
Surgical Oncology|April 25, 2022
Minimally invasive surgery versus percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma: Results from a high-volume liver surgery center in East AsiaYueh-Wei Liu, Yi-Hao Yen, Wei-Feng Li, et al.
Clinical Medicine Insights. Oncology|March 7, 2024
Smoking as a Risk Factor for Very Late Recurrence in Surgically Resected Early-Stage Primary Hepatocellular CarcinomaWei-Ru Cho, Chih-Chi Wang, Mu-Jung Tsai, et al.
Journal of Gastroenterology and Hepatology|July 28, 2010
Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screeningPo-Lin Tseng, Jing-Houng Wang, Hung-Da Tung, et al.
Pageof 57